The DOI matches its Crossref record, with a small difference in title or year; 29 of the 29 references it cites were found in a registry or an index.
Effect of Early Vasopressin vs Norepinephrine on Kidney Failure in Patients With Septic Shock: The VANISH Randomized Clinical Trial
Open accessAbstract
IMPORTANCE: Norepinephrine is currently recommended as the first-line vasopressor in septic shock; however, early vasopressin use has been proposed as an alternative. OBJECTIVE: To compare the effect of early vasopressin vs norepinephrine on kidney failure in patients with septic shock. DESIGN, SETTING, AND PARTICIPANTS: A factorial (2×2), double-blind, randomized clinical trial conducted in 18 general adult intensive care units in the United Kingdom between February 2013 and May 2015, enrolling adult patients who had septic shock requiring vasopressors despite fluid resuscitation within a maximum of 6 hours after the onset of shock. INTERVENTIONS: Patients were randomly allocated to vasopressin (titrated up to 0.06 U/min) and hydrocortisone (n = 101), vasopressin and placebo (n = 104), norepinephrine and hydrocortisone (n = 101), or norepinephrine and placebo (n = 103). MAIN OUTCOMES AND MEASURES: The primary outcome was kidney failure-free days during the 28-day period after randomization, measured as (1) the proportion of patients who never developed kidney failure and (2) median number of days alive and free of kidney failure for patients who did not survive, who experienced kidney failure, or both. Rates of renal replacement therapy, mortality, and serious adverse events were secondary outcomes. RESULTS: A total of 409 patients (median age, 66 years; men, 58.2%) were included in the study, with a median time to study drug administration of 3.5 hours after diagnosis of shock. The number of survivors who never developed kidney failure was 94 of 165 patients (57.0%) in the vasopressin group and 93 of 157 patients (59.2%) in the norepinephrine group (difference, -2.3% [95% CI, -13.0% to 8.5%]). The median number of kidney failure-free days for patients who did not survive, who experienced kidney failure, or both was 9 days (interquartile range [IQR], 1 to -24) in the vasopressin group and 13 days (IQR, 1 to -25) in the norepinephrine group (difference, -4 days [95% CI, -11 to 5]). There was less use of renal replacement therapy in the vasopressin group than in the norepinephrine group (25.4% for vasopressin vs 35.3% for norepinephrine; difference, -9.9% [95% CI, -19.3% to -0.6%]). There was no significant difference in mortality rates between groups. In total, 22 of 205 patients (10.7%) had a serious adverse event in the vasopressin group vs 17 of 204 patients (8.3%) in the norepinephrine group (difference, 2.5% [95% CI, -3.3% to 8.2%]). CONCLUSIONS AND RELEVANCE: Among adults with septic shock, the early use of vasopressin compared with norepinephrine did not improve the number of kidney failure-free days. Although these findings do not support the use of vasopressin to replace norepinephrine as initial treatment in this situation, the confidence interval included a potential clinically important benefit for vasopressin, and larger trials may be warranted to assess this further. TRIAL REGISTRATION: clinicaltrials.gov Identifier: ISRCTN 20769191.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Most studies were observational, and there are concerns that de-escalation is used primarily in patients who are getting better, which is why the reported improved short-term mortality should be interpreted with caution (277,279).”
From Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2021. (2021) · cites this paper as [279]
Experimental — accuracy not yet measuredIn the citing paper
“Although there was no difference with respect to kidney injury (RR 0.89; 95% CI 0.72–1.11), vasopressin use reduced the risk of RRT (RR 0.71; 95% CI 0.53–0.97) [354].”
From Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021 (2021) · cites this paper as [354]
In the citing paper
“There was no significant difference between the vasopressin and norepinephrine groups in 28-day mortality [30.9% vs 27.5%; RR 1.13 (95% CI 0.85–1.51).”
From Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021 (2021) · cites this paper as [354]
In the citing paper
“Several meta-analyses suggest decreased mortality in patients with a pressure- and volume-limited strategy for established ARDS [353, 354].”
From Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021 (2021) · cites this paper as [354]
In the citing paper
“In the ADRENAL [479] study, hydrocortisone was administered for a maximum of seven days or until ICU discharge or death; in APROCCHSS [478] hydrocortisone was administered for seven days; in VANISH [354] 200 mg of hydrocortisone was administered daily for 5 days and then tapered over further 6 days.”
From Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021 (2021) · cites this paper as [354]
In the citing paper
“Since then, three large RCTs have been published [354, 478, 479].”
From Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021 (2021) · cites this paper as [354]
In the citing paper
“The optimal dose, timing of initiation, and duration of corticosteroids remain uncertain; recent RCTs used 200 mg per day of IV hydrocortisone in divided doses [354, 479].”
From Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021 (2021) · cites this paper as [354]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bone, R. C., BALK, R. A., Cerra, F. B., Dellinger, R. P., Fein, A. M., Knaus, W. A., Schein, R. M. H., & Sibbald, W. J. (1992) · CHEST Journal · doi:10.1378/chest.101.6.1644 · Cited by 13,317
Vincent, J. L., Moreno, R., Takala, J., Willatts, S., De Mendonça, A., Bruining, H., Reinhart, C. K., Suter, P. M., & Thijs, L. G. (1996) · Intensive Care Medicine · doi:10.1007/bf01709751 · Cited by 11,674
Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock
Dellinger, R. P., Levy, M. M., Rhodes, A., Annane, D., Gerlach, H., Opal, S. M., Sevransky, J. E., Sprung, C. L., Douglas, I. S., Jaeschke, R., et al. (2013) · Critical Care Medicine · doi:10.1097/ccm.0b013e31827e83af · Cited by 9,694
Dellinger, R. P., Levy, M. M., Rhodes, A., Annane, D., Gerlach, H., Opal, S. M., Sevransky, J., Sprung, C. L., Douglas, I. S., Jaeschke, R., et al. (2013) · Intensive Care Medicine · doi:10.1007/s00134-012-2769-8 · Cited by 7,371
Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury
Mehta, R. L., Kellum, J. A., Shah, S. V., Molitoris, B. A., Ronco, C., Warnock, D. G., Levin, A., & the Acute Kidney Injury Network (2007) · Critical Care · doi:10.1186/cc5713 · Cited by 7,046
Dellinger, R. P., Levy, M. M., Carlet, J. M., Bion, J., Parker, M. M., Jaeschke, R., Reinhart, K., Angus, D. C., Brun‐Buisson, C., Beale, R. J., et al. (2007) · Intensive Care Medicine · doi:10.1007/s00134-007-0934-2 · Cited by 6,789
Hydrocortisone Therapy for Patients with Septic Shock
Sprung, C. L., Annane, D., Keh, D., Moreno, R. P., Singer, M., Freivogel, K., Weiss, Y., Benbenishty, J. S., Kalenka, A., Forst, H., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa071366 · Cited by 2,162
Vasopressin versus Norepinephrine Infusion in Patients with Septic Shock
Russell, J. A., Walley, K. R., Singer, J., Gordon, A. C., Hébert, P. C., Cooper, D. J., Holmes, C. L., Mehta, S., Granton, J. T., Storms, M. M., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa067373 · Cited by 1,924
Self-citationHigh versus low blood-pressure target in patients with septic shock.
Asfar, P., Meziani, F., Hamel, J.-F., Grelon, F., Megarbane, B., Anguel, N., Mira, J.-P., Dequin, P.-F., Gergaud, S., Weiss, N., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1312173 · Cited by 1,239
Vasopressin Deficiency Contributes to the Vasodilation of Septic Shock
Landry, D. W., Levin, H. R., Gallant, E. M., Ashton, R. C., Seo, S., D'Alessandro, D., Oz, M. C., & Oliver, J. A. (1997) · Circulation · doi:10.1161/01.cir.95.5.1122 · Cited by 990
Flagged first, then by citations
Cited by
Sorted by citations
Items 101–200 of 723
Is Mortality a Useful Primary End Point for Critical Care Trials?
Veldhoen, R. A., Howes, D. W., & Maslove, D. M. (2019) · CHEST Journal · doi:10.1016/j.chest.2019.11.019 · Cited by 49
Qiao, J., & Cui, L. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.905601 · Cited by 48
Efficacy and Safety of the Early Addition of Vasopressin to Norepinephrine in Septic Shock
Hammond, D. A., Cullen, J., Painter, J. T., McCain, K., Clem, O. A., Brotherton, A. L., Chopra, D., & Meena, N. K. (2017) · Journal of Intensive Care Medicine · doi:10.1177/0885066617725255 · Cited by 47
Hussain, H., Vutipongsatorn, K., Jiménez, B., & Antcliffe, D. B. (2022) · Metabolites · doi:10.3390/metabo12050376 · Cited by 47
Xu, J., Cai, H., & Zheng, X. (2023) · BMC Infectious Diseases · doi:10.1186/s12879-023-08147-6 · Cited by 45
Chow, J. H., Abuelkasem, E., Sankova, S. K., Henderson, R. A., Mazzeffi, M. A., & Tanaka, K. A. (2019) · Anesthesia & Analgesia · doi:10.1213/ane.0000000000004343 · Cited by 47
Lat, I., Coopersmith, C. M., & Backer, D. D. (2021) · Critical Care Medicine · doi:10.1097/ccm.0000000000004864 · Cited by 44
Pediatric sepsis biomarkers for prognostic and predictive enrichment
Wong, H. R. (2021) · Pediatric Research · doi:10.1038/s41390-021-01620-5 · Cited by 47
Machine-learning-derived sepsis bundle of care
Kalimouttou, A., Lerner, I., Cheurfa, C., Jannot, A., & Pirracchio, R. (2022) · Intensive Care Medicine · doi:10.1007/s00134-022-06928-2 · Cited by 45
Zhang, J., Yan, W., Dong, Y., Luo, X., Miao, H., Maimaijuma, T., Xu, X., Jiang, H., Huang, Z., Qi, L., et al. (2024) · Journal of Thoracic Disease · doi:10.21037/jtd-24-1191 · Cited by 45
The Japanese Clinical Practice Guidelines for Management of Sepsis and Septic Shock 2024
Shime, N., Nakada, T.-A., Yatabe, T., Yamakawa, K., Aoki, Y., Inoue, S., Iba, T., Ogura, H., Kawai, Y., Kawaguchi, A., et al. (2025) · Journal of Intensive Care · doi:10.1186/s40560-025-00776-0 · Cited by 45
A Systematic Approach to the Treatment of Vasoplegia Based on Recent Advances in Pharmacotherapy
Ortoleva, J. P., & Cobey, F. C. (2018) · Journal of Cardiothoracic and Vascular Anesthesia · doi:10.1053/j.jvca.2018.11.025 · Cited by 44
Cheng, L., Yan, J., Han, S., Chen, Q., Chen, M., Jiang, H., & Lü, J. (2019) · Critical Care · doi:10.1186/s13054-019-2427-4 · Cited by 45
Santhakumaran, S., Gordon, A. C., Prevost, A. T., O’Kane, C. M., McAuley, D. F., & Shankar‐Hari, M. (2019) · Critical Care · doi:10.1186/s13054-019-2446-1 · Cited by 43
Self-citationKidney Dysfunction After Traumatic Brain Injury: Pathophysiology and General Management
Vlieger, G. D., & Meyfroidt, G. (2022) · Neurocritical Care · doi:10.1007/s12028-022-01630-z · Cited by 43
Xu, Z., Cheng, B., Fu, S., Liu, X., Xie, G., Li, Z., Ji, Y. S., Fu, Q., Xu, Z., & Fang, X. (2019) · Infection and Drug Resistance · doi:10.2147/idr.s218592 · Cited by 42
Adrenergic Downregulation in Critical Care: Molecular Mechanisms and Therapeutic Evidence
Belletti, A., Landoni, G., Ломиворотов, В. В., Oriani, A., & Ajello, S. (2019) · Journal of Cardiothoracic and Vascular Anesthesia · doi:10.1053/j.jvca.2019.10.017 · Cited by 43
Hussein, A. A., Sabry, N. A., Abdalla, M. S., & Farid, S. F. (2021) · International Journal of Clinical Practice · doi:10.1111/ijcp.14376 · Cited by 41
Sims, C. R., & Comfere, T. B. (2019) · Oxford University Press eBooks · doi:10.1093/med/9780190862923.003.0060 · Cited by 39
Review: sepsis guidelines and core measure bundles
Desposito, L., & Bascara, C. J. (2024) · Postgraduate Medicine · doi:10.1080/00325481.2024.2388021 · Cited by 40
Fluids and Early Vasopressors in the Management of Septic Shock: Do We Have the Right Answers Yet?
Sanchez, E. C., Pinsky, M. R., Sinha, S., Mishra, R. C., Lopa, A. J., & Chatterjee, R. (2023) · The Journal of Critical Care Medicine · doi:10.2478/jccm-2023-0022 · Cited by 41
White, K. C., Costa‐Pinto, R., Blank, S. P., Whebell, S. F., Quick, L., Luke, S., Attokaran, A. G., Garrett, P., Ramanan, M., Tabah, A., et al. (2025) · Critical Care · doi:10.1186/s13054-025-05401-y · Cited by 39
Sacha, G. L., Lam, S. W., Duggal, A., Torbic, H., Reddy, A. J., & Bauer, S. R. (2018) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.2082 · Cited by 40
Vasoactive Agent Use in Septic Shock: Beyond First‐Line Recommendations
Sacha, G. L., Bauer, S. R., & Lat, I. (2019) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.2220 · Cited by 40
Jiang, L., Sheng, Y., Feng, X., & Wu, J. (2019) · Critical Care · doi:10.1186/s13054-019-2362-4 · Cited by 40
Leisman, D. E., Handisides, D. R., Busse, L. W., Chappell, M. C., Chawla, L. S., Filbin, M. R., Goldberg, M. B., Ham, K. R., Khanna, A. K., Ostermann, M., et al. (2024) · Critical Care · doi:10.1186/s13054-024-04910-6 · Cited by 37
Vasopressin and its analogues in patients with septic shock: holy Grail or unfulfilled promise?
Lajoye, Q., Orieux, A., Boyer, A., Prével, R., & Jozwiak, M. (2025) · Critical Care · doi:10.1186/s13054-025-05540-2 · Cited by 38
The SEP-1 quality mandate may be harmful: How to drown a patient with 30 mL per kg fluid!
Marik, P. E., & Malbrain, M. L. N. G. (2017) · Anaesthesiology Intensive Therapy · doi:10.5603/ait.a2017.0056 · Cited by 38
Butler, E., Møller, M. H., Cook, O., Granholm, A., Penketh, J., Rygård, S. L., Åneman, A., & Perner, A. (2019) · Intensive Care Medicine · doi:10.1007/s00134-019-05754-3 · Cited by 37
Biomarkers and Precision Medicine
Sarma, A. A., Calfee, C. S., & Ware, L. B. (2019) · Critical Care Clinics · doi:10.1016/j.ccc.2019.08.012 · Cited by 39
Lat, I., Coopersmith, C. M., Backer, D. D., & Coopersmith, C. M. (2021) · Intensive Care Medicine Experimental · doi:10.1186/s40635-021-00369-9 · Cited by 37
Кirov, М. Y., Владимирович, К. В., Николаевич, П. Д., Щеголев, А. В., Babaev, M. A., Belotserkovskiy, B. Z., Bykov, A. O., Gritsan, A. I., Кулабухов, В. В., Kulikov, A. V., et al. (2023) · Annals of critical care · doi:10.21320/1818-474x-2023-4-7-42 · Cited by 38
Is APACHE II a useful tool for clinical research?
Moreno, R. P., & Nassar, A. P. (2017) · Revista Brasileira de Terapia Intensiva · doi:10.5935/0103-507x.20170046 · Cited by 39
Role of vasopressin in current anesthetic practice
Park, K. S., & Yoo, K. Y. (2017) · Korean Journal of Anesthesiology · doi:10.4097/kjae.2017.70.3.245 · Cited by 37
Norepinephrine in Septic Shock: A Systematic Review and Meta-analysis
bin Ruslan, M. R., Baharuddin, K. A., Norhayati, M. N., Yazid, M., Noh, A. Y. M., & Rahman, A. (2021) · Western Journal of Emergency Medicine · doi:10.5811/westjem.2020.10.47825 · Cited by 35
Incidence and outcomes of acute kidney injury stratified by cardiogenic shock severity
Padkins, M. R., Breen, T. J., van Diepen, S., Barsness, G. W., KASHANI, K. B., & Jentzer, J. C. (2021) · Catheterization and Cardiovascular Interventions · doi:10.1002/ccd.29692 · Cited by 36
Chen, L., Wu, X., Qin, H., & Zhu, H. (2021) · Frontiers in Nutrition · doi:10.3389/fnut.2021.584461 · Cited by 36
Angiotensin II: a new therapeutic option for vasodilatory shock
Bussard, R. L., & Busse, L. W. (2018) · Therapeutics and Clinical Risk Management · doi:10.2147/tcrm.s150434 · Cited by 34
A clinical approach to acute mesenteric ischemia
Reintam Blaser, A., Acosta, S., & Arabi, Y. M. (2021) · Current Opinion in Critical Care · doi:10.1097/mcc.0000000000000802 · Cited by 33
Vasopressin in Sepsis and Other Shock States: State of the Art
García-Álvarez, R., & Arboleda-Salazar, R. (2023) · Journal of Personalized Medicine · doi:10.3390/jpm13111548 · Cited by 33
Antcliffe, D. B., Mi, Y., Santhakumaran, S., Burnham, K. L., Prevost, A. T., Ward, J. K., Marshall, T. J., Bradley, C., Al-Beidh, F., Hutton, P., et al. (2024) · Thorax · doi:10.1136/thorax-2023-220538 · Cited by 33
Self-citationPitre, T., Pauley, E., Chaudhuri, D., Saha, R., Rudd, K. E., Villar, J., Berry, L. R., Lorenzi, E., Hills, T. E., Nichol, A., et al. (2025) · Intensive Care Medicine · doi:10.1007/s00134-025-07912-2 · Cited by 33
Self-citationReview of research progress in sepsis-associated acute kidney injury
Nian, W., Tao, W., & Zhang, H. (2025) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2025.1603392 · Cited by 33
Wu, Z., Zhang, S., Xu, J., Xie, J., Huang, L., Huang, Y., Yang, Y., & Qiu, H. (2019) · Shock · doi:10.1097/shk.0000000000001345 · Cited by 33
Risk factors for new-onset atrial fibrillation on the general adult ICU: A systematic review
Bedford, J., Harford, M., Petrinic, T., Young, D., & Watkinson, P. (2019) · Journal of Critical Care · doi:10.1016/j.jcrc.2019.06.015 · Cited by 33
Management of Acute Kidney Injury Following Major Abdominal Surgery: A Contemporary Review
Gameiro, J., Fonseca, J. A., Marques, F. C., & Lopes, J. A. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9082679 · Cited by 35
Infection, Sepsis and the Inflammatory Response: Mechanisms and Therapy
Lonsdale, D., Shah, R. V., & Lipman, J. (2020) · Frontiers in Medicine · doi:10.3389/fmed.2020.588863 · Cited by 33
Akatsuka, M., Masuda, Y., Tatsumi, H., & Sonoda, T. (2020) · Journal of Intensive Care · doi:10.1186/s40560-020-00512-w · Cited by 32
Huang, H., Wu, C., Shen, Q., Xu, H., Fang, Y., & Mao, W. (2021) · The American Journal of Emergency Medicine · doi:10.1016/j.ajem.2021.05.007 · Cited by 32
What is new and different in the 2021 Surviving Sepsis Campaign guidelines
Prescott, H. C., & Ostermann, M. (2023) · Medizinische Klinik - Intensivmedizin und Notfallmedizin · doi:10.1007/s00063-023-01028-5 · Cited by 37
Renal perfusion pressure: role and implications in critical illness
Panwar, R., McNicholas, B., Teixeira, J. P., & Kansal, A. (2025) · Annals of Intensive Care · doi:10.1186/s13613-025-01535-y · Cited by 39
Efficacy and Outcomes After Vasopressin Guideline Implementation in Septic Shock
Wu, J., Stollings, J. L., Wheeler, A. P., Semler, M. W., & Rice, T. W. (2016) · Annals of Pharmacotherapy · doi:10.1177/1060028016669163 · Cited by 32
Nedel, W. L., Rech, T. H., Ribeiro, R. A., Pellegrini, J. A. S., & Moraes, R. B. (2018) · Critical Care Medicine · doi:10.1097/ccm.0000000000003471 · Cited by 32
Sepsis in the critically ill patient: current and emerging management strategies
Heming, N., Azabou, É., Cazaumayou, X., Moine, P., & Annane, D. (2020) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2021.1846522 · Cited by 32
Guinot, P., Martin, A., Berthoud, V., Voizeux, P., Bartamian, L., Santangelo, E., Bouhemad, B., & Nguyen, M. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10143164 · Cited by 33
Optimizing Vasopressin Use and Initiation Timing in Septic Shock
Sacha, G. L., & Bauer, S. R. (2023) · CHEST Journal · doi:10.1016/j.chest.2023.07.009 · Cited by 31
Jia, L., Wang, P., Li, C., & Xie, J. (2023) · Shock · doi:10.1097/shk.0000000000002193 · Cited by 31
S3-Leitlinie Sepsis – Prävention, Diagnose, Therapie und Nachsorge – Update 2025
Brunkhorst, F. M., Adamzik, M., Axer, H., Bauer, M. W., Bode, C., Bone, H.-G., Brenner, T., Bucher, M., David, S., Dietrich, M., et al. (2025) · Medizinische Klinik - Intensivmedizin und Notfallmedizin · doi:10.1007/s00063-025-01317-1 · Cited by 35
Miao, H., Shi, J., Wang, C., Lü, G., Zhu, X., Wang, Y., Cui, Y., & Zhang, Y. (2019) · Critical Care Medicine · doi:10.1097/ccm.0000000000003901 · Cited by 31
Sepsis and Adrenal Insufficiency
Fowler, C., Raoof, N. D., & Pastores, S. M. (2023) · Journal of Intensive Care Medicine · doi:10.1177/08850666231183396 · Cited by 30
Expert consensus on blood pressure management in critically ill patients
Yu, Y., Gong, Y., Hu, B., Ouyang, B., Pan, A., Liu, J., Liu, F., Shang, X., Yang, X., Tu, G.-W., et al. (2023) · Journal of Intensive Medicine · doi:10.1016/j.jointm.2023.06.001 · Cited by 32
S3-Leitlinie Sepsis – Prävention, Diagnose, Therapie und Nachsorge
Deutsche Sepsis Gesellschaft e., V., Brunkhorst, F. M., Weigand, M. A., Pletz, M. W., Gastmeier, P., Lemmen, S., Meier‐Hellmann, A., Ragaller, M., Weyland, A., Marx, G., et al. (2020) · Medizinische Klinik - Intensivmedizin und Notfallmedizin · doi:10.1007/s00063-020-00671-6 · Cited by 31
Perioperative Renoprotection: General Mechanisms and Treatment Approaches
Molinari, L., Sakhuja, A., & Kellum, J. A. (2020) · Anesthesia & Analgesia · doi:10.1213/ane.0000000000005107 · Cited by 31
Hemodynamic Monitoring and Support
Vincent, J., Joosten, A., & Saugel, B. (2021) · Critical Care Medicine · doi:10.1097/ccm.0000000000005213 · Cited by 30
Hemodynamic management of septic shock: beyond the Surviving Sepsis Campaign guidelines
Suh, G. J., Shin, T. G., Kwon, W. Y., Kim, K., Jo, Y. H., Choi, S., Chung, S. P., Kim, W. Y., & for the Korean Shock Society investigators (2023) · Clinical and Experimental Emergency Medicine · doi:10.15441/ceem.23.065 · Cited by 30
Self-citationVasopressors to treat refractory septic shock
Meresse, Z., Medam, S., Mathieu, C., Duclos, G., Vincent, J., & Léone, M. (2020) · Minerva Anestesiologica · doi:10.23736/s0375-9393.20.13826-4 · Cited by 33
Emergency medicine updates: Management of sepsis and septic shock
Long, B., & Gottlieb, M. A. (2025) · The American Journal of Emergency Medicine · doi:10.1016/j.ajem.2025.01.054 · Cited by 29
Sepsis subphenotypes: bridging the gaps in sepsis treatment strategies
Zhang, X., Zhang, W., Zhang, H., & Liao, X. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1546474 · Cited by 30
Catecholamine Vasopressor Support Sparing Strategies in Vasodilatory Shock
Buckley, M. S., Barletta, J. F., Smithburger, P. L., Radosevich, J. J., & Kane‐Gill, S. L. (2018) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.2199 · Cited by 29
Fong, K. M., Au, S. Y., & Ng, G. W. Y. (2021) · Scientific Reports · doi:10.1038/s41598-021-95386-9 · Cited by 29
Buckel, M., Maclean, P., Knight, J. C., Lawler, P. R., & Proudfoot, A. G. (2023) · Critical Care · doi:10.1186/s13054-023-04752-8 · Cited by 30
Long-term prognosis of septic shock in cancer patients
Camou, F., Didier, M., Leguay, T., Milpied, N. J., Daste, A., Ravaud, A., Mourissoux, G., Guisset, O., & Issa, N. (2019) · Supportive Care in Cancer · doi:10.1007/s00520-019-04937-4 · Cited by 30
Management of Vasoplegic Shock in the Cardiovascular Intensive Care Unit after Cardiac Surgery
Suero, O. R., Park, Y., Wieruszewski, P. M., & Chatterjee, S. (2023) · Critical Care Clinics · doi:10.1016/j.ccc.2023.06.002 · Cited by 28
Rajendran, S., Xu, Z., Pan, W., Zang, C., Siempos, I. Ι., Torres, L. K., Xu, J., Bian, J., Schenck, E. J., & Wang, F. (2025) · Nature Communications · doi:10.1038/s41467-025-59643-z · Cited by 29
Shankar‐Hari, M., Santhakumaran, S., Prevost, A. T., Ward, J. K., Marshall, T. J., Bradley, C., Calfee, C. S., Delucchi, K., Sinha, P., Matthay, M. A., et al. (2021) · Efficacy and Mechanism Evaluation · doi:10.3310/eme08100 · Cited by 28
Self-citationVasopressin in Vasodilatory Shock
Ukor, I.-F., & Walley, K. R. (2019) · Critical Care Clinics · doi:10.1016/j.ccc.2018.11.004 · Cited by 27
Lian, X., Huang, D., Cao, Y., Wei, Y.-X., Lian, Z., Qin, T., He, P.-C., Liu, Y.-H., & Wang, S. (2019) · BioMed Research International · doi:10.1155/2019/3175047 · Cited by 27
Sepsis Management for the Nephrologist
Patel, S., Puri, N., & Dellinger, R. P. (2022) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.14381121 · Cited by 28
Wang, J., Shi, M., Huang, L., Li, Q., Meng, S., Xu, J., Xue, M., Xie, J., Liu, S., & Huang, Y. (2022) · Renal Failure · doi:10.1080/0886022x.2022.2095286 · Cited by 29
Aiming for precision: personalized medicine through sepsis subtyping
Kolodyazhna, A., Wiersinga, W. J., & van der Poll, T. (2024) · Burns & Trauma · doi:10.1093/burnst/tkae073 · Cited by 29
Metabolic septic shock sub-phenotypes, stability over time and association with clinical outcome
Antcliffe, D. B., Harte, E., Hussain, H., Jiménez, B., Browning, C., & Gordon, A. C. (2025) · Intensive Care Medicine · doi:10.1007/s00134-025-07859-4 · Cited by 26
Self-citationAlternatives to norepinephrine in septic shock: Which agents and when?
Jozwiak, M. (2022) · Journal of Intensive Medicine · doi:10.1016/j.jointm.2022.05.001 · Cited by 27
Kotani, Y., Belletti, A., D’Amico, F., Bonaccorso, A., Wieruszewski, P. M., Fujii, T., Khanna, A. K., Landoni, G., & Bellomo, R. (2024) · Critical Care · doi:10.1186/s13054-024-05212-7 · Cited by 25
Gazmuri, R. J., & de Gomez, C. A. (2020) · Journal of Critical Care · doi:10.1016/j.jcrc.2019.11.008 · Cited by 25
Vincent, J., & Grimaldi, D. (2017) · Critical Care Clinics · doi:10.1016/j.ccc.2017.08.012 · Cited by 25
Why My Steroid Trials in Septic Shock Were “Positive”
Annane, D. (2019) · Critical Care Medicine · doi:10.1097/ccm.0000000000003889 · Cited by 27
Donaldson, L., Vlok, R. A., Sakurai, K., Burrows, M., McDonald, G., Venkatesh, K., Bagshaw, S. M., Bellomo, R., Delaney, A. P., Myburgh, J., et al. (2024) · Critical Care Medicine · doi:10.1097/ccm.0000000000006284 · Cited by 24
New strategies to optimize renal haemodynamics
Suarez, J., & Busse, L. W. (2020) · Current Opinion in Critical Care · doi:10.1097/mcc.0000000000000774 · Cited by 24
How We Escalate Vasopressor and Corticosteroid Therapy in Patients With Septic Shock
Teja, B. J., Bosch, N. A., & Walkey, A. J. (2022) · CHEST Journal · doi:10.1016/j.chest.2022.09.019 · Cited by 26
Corticosteroids for treating sepsis in children and adults
Annane, D., Briegel, J., Granton, D., Bellissant, É., Bollaert, P., Keh, D., Kupfer, Y. Y., Pirracchio, R., & Rochwerg, B. N. (2025) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002243.pub5 · Cited by 23
Evolving Paradigms in Sepsis Management: A Narrative Review
Kim, M., Choi, E.-J., & Choi, E.-J. (2024) · Cells · doi:10.3390/cells13141172 · Cited by 24
Renal Blood Flow, Glomerular Filtration Rate, and Renal Oxygenation in Early Clinical Septic Shock*
Larsson, J. S., Krumbholz, V., Enskog, A., Bragadottir, G., Redfors, B., & Ricksten, S. (2018) · Critical Care Medicine · doi:10.1097/ccm.0000000000003088 · Cited by 23
Jabaley, C. S., Groff, R. F., Stentz, M. J., Moll, V., Lynde, G. C., Blum, J. M., & O’Reilly-Shah, V. N. (2018) · Journal of Critical Care · doi:10.1016/j.jcrc.2018.09.033 · Cited by 23
Onichimowski, D., Będźkowska, A., Ziółkowski, H., JAROSZEWSKI, J. J., Borys, M., Czuczwar, M., & Wiczling, P. (2020) · Pharmacological Reports · doi:10.1007/s43440-020-00104-3 · Cited by 23
Vincent, J., & Annoni, F. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13237372 · Cited by 22
Organ donor management: Eight common recommendations and actions that deserve reflection
Chamorro-Jambrina, C., Muñoz-Ramírez, M. R., Martínez-Melgar, J. L., & Pérez-Cornejo, M. S. (2017) · Medicina Intensiva · doi:10.1016/j.medin.2017.01.012 · Cited by 22
Outcome of acute kidney injury: how to make a difference?
Jamme, M., Legrand, M. M., & Géri, G. (2021) · Annals of Intensive Care · doi:10.1186/s13613-021-00849-x · Cited by 23
Yao, L., Rey, D. A., Bulgarelli, L., Kast, R. E., Osborn, J., Ark, E. V., Fang, L. T., Lau, B., Lam, H. Y. K., Teixeira, L. M., et al. (2022) · Shock · doi:10.1097/shk.0000000000001910 · Cited by 22
Kothari, N., Sharma, A. D., Goyal, S., Bhatia, P. K., & Sahoo, P. (2022) · Indian Journal of Critical Care Medicine · doi:10.5005/jp-journals-10071-24231 · Cited by 22
Lai, P.-C., Lai, C., Lai, E. C., & Huang, Y. (2023) · Critical Care Medicine · doi:10.1097/ccm.0000000000006161 · Cited by 22
Metadata
- Authors
- Gordon, A. C., Mason, A. J., Thirunavukkarasu, N., Perkins, G. D., Cecconi, M., Cepkova, M., Pogson, D. G., Aya, H. D., Anjum, A., Frazier, G. J., Santhakumaran, S., Ashby, D., Brett, S. J., & for the VANISH Investigators
- Affiliations
- Imperial College London (GB)
- London School of Hygiene & Tropical Medicine (GB)
- University of Warwick (GB)
- National Health Service (GB)
- Corresponding author
- Gordon, Anthony C.
- ORCID
- Venue
- JAMA
- Publisher
- American Medical Association (AMA)
- Published
- 2016-08-02
- Volume
- 316
- Issue
- 5
- Pages
- 509
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- OpenAlex
- W2489536306
- Semantic Scholar
- 0a2e8f0595aed35457448e71c5f52e2cd0ccb618
- Cited by
- 728
- References
- 29
- Citations by year
- 2026: 77 · 2025: 114 · 2024: 82 · 2023: 69 · 2022: 59 · 2021: 61 · 2020: 67 · 2019: 83 · 2018: 62 · 2017: 40 · 2016: 12
- FWCI
- 61.17
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- JAMA (publishedVersion)
- PubMed (publishedVersion)
- University of Brighton Repository (University of Brighton) (publishedVersion, other-oa)
- LSHTM Research Online (London School of Hygiene and Tropical Medicine) (acceptedVersion)
- Warwick Research Archive Portal (University of Warwick) (acceptedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Research Portal (King's College London) (submittedVersion, other-oa)
- Queen Mary Research Online (Queen Mary University of London) (submittedVersion)
- Spiral (Imperial College London) (submittedVersion)
- Warwick Research Archive Portal (University of Warwick) (submittedVersion)
- Funders
- University of Portsmouth
- Intensive Care Foundation
- University Hospital Southampton NHS Foundation Trust
- National Institute for Health and Care Research (NF-SI-0514-10139, NIHR/CS/009/007, PB-PG-0610-22350)
- Imperial College London
- Imperial College Healthcare NHS Trust
- Barts Health NHS Trust
- University Hospitals Coventry and Warwickshire NHS Trust
- Topics
- Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Sepsis Diagnosis and Treatment
- Health Sciences › Medicine › Nephrology › Acute Kidney Injury Research
- Health Sciences › Medicine › Surgery › Hemodynamic Monitoring and Therapy
- Keywords
- septic shock, vasopressin, norepinephrine, renal failure, acute kidney injury, vasopressor therapy, cortisol, renal replacement therapy, mortality, intensive care unit patients, fluid resuscitation, serious adverse events, 90-day outcomes
- MeSH terms
- Adult, Aged, Aged, 80 and over, Critical Care, Double-Blind Method, Drug Administration Schedule, Female, Fluid Therapy, United Kingdom, Humans, Hydrocortisone, Intensive Care Units, Male, Middle Aged, Norepinephrine, Shock, Septic, Vasoconstrictor Agents, Vasopressins, Treatment Outcome, Renal Replacement Therapy, Renal Insufficiency
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
